Barely Significant
← all excerpts

Efficacy and safety of scheduled rituximab in children with refractory nephrotic syndrome after multi-target therapy failure.

Pediatr Nephrol · 2026 · PMC13009123 · PMID 41385077

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
This represents a highly significant reduction in relapse rate compared to the pre-RTX period (paired t -test, p < 0.0001; see Figure 1 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.